This example shows a subset of published controlled terminology parameters and the relationship of values across response variables TSVAL, TSVALNF, TSVALCD, TSVCDREF, and TSVCDVER. Text over 200 characters can be added to additional columns TSVAL1-TSVALn. This example include the subset of terms that are CDISC and FDA required. When required items are not applicable TSVALNF may be used.
TSVALNF contains a “null flavor,” a value that provides additional coded information when TSVAL is null. For example, for TSPARM = "AGEMAX" (Planned Maximum Age of Subjects), there is no value if a study does not specify a maximum age. In this case, the appropriate null flavor is "PINF", which stands for "positive infinity." In a clinical pharmacology study conducted in healthy volunteers for a drug where indications are not yet established, the appropriate null flavor for TSPARM = "INDIC" (Trial Disease/Condition Indication) would be "NA" (i.e., not applicable). TSVALNF can also be used in a case where the value of a particular parameter is unknown.
ts.xpt
ts.xpt
Row
STUDYID
DOMAIN
TSSEQ
TSGRPID
TSPARMCD
TSPARM
TSVAL
TSVAL1
TSVALNF
TSVALCD
TSVCDREF
TSVCDVER
1
XYZ
TS
1
ACTSUB
Actual Number of Subjects
304
2
XYZ
TS
1
ADAPT
Adaptive Design
N
3
XYZ
TS
1
ADDON
Added on to Existing Treatments
Y
C49487
CDISC CT
2011-06-10
4
XYZ
TS
1
AGEMAX
Planned Maximum Age of Subjects
P70Y
ISO 8601
5
XYZ
TS
1
AGEMIN
Planned Minimum Age of Subjects
P18M
ISO 8601
6
XYZ
TS
1
PA
DCUTDTC
Data Cutoff Date
2010-04-10
ISO 8601
7
XYZ
TS
1
PA
DCUTDESC
Data Cutoff Description
PRIMARY ANALYSIS
8
XYZ
TS
1
FCNTRY
Planned Country of Investigational Sites
USA
ISO 3166-1 Alpha-3
9
XYZ
TS
2
FCNTRY
Planned Country of Investigational Sites
CAN
ISO 3166-1 Alpha-3
10
XYZ
TS
1
HLTSUBJI
Healthy Subject Indicator
NA
C48660
CDISC CT
2011-06-10
11
XYZ
TS
1
INDIC
Trial Disease/Condition Indication
Tobacco smoking consumption
266918002
SNOMED
2011-03
12
XYZ
TS
1
LENGTH
Trial Length
P3M
ISO 8601
13
XYZ
TS
1
NARMS
Planned Number of Arms
3
14
XYZ
TS
1
OBJPRIM
Trial Primary Objective
Change in concentration of Nicotine in urine from baseline
15
XYZ
TS
1
OBJSEC
Trial Secondary Objective
Change in concentration of Cotinine in urine from baseline